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The family of proteins named neurotrophins and also their receptors play an important role in differentiation and survival of 
specific populations of neurons, including cutaneous nerves. Recent advance in neuroscience has shown that in addition to their 
neurotrophic actions, neurotrophins, particularly, nerve growth factor, mediate various immune and inflammatory responses. 
These functions are fulfilled by alterations in cytokine and neuropeptide production, through effects on neurotrophin receptor- 
bearing immune cells, notably, mast cells, lymphocytes, and macrophages. Within skin, different neurotrophins are synthesize 
and release primarily by keratinocytes, thus affecting cutaneous innervation, postinjury neural reconstruction, and nonneuronal 
cells, such as melanocytes, through a paracrine action. Involvement of neurotrophins and their receptors in the pathogenesis 
of certain skin diseases is also reviewed. Biomed Rev 1999; 10:15-23. 
 
THE NOBEL PRIZE 
In October 19 8 6, the Nobel Assembly at the Karolinska Institute 
in Stockholm announced that the 1986 year's Nobel Prize in 
Physiology or Medicine is awarded to Rita Levi-Montalcini, 
Rome, Italy and Stanley Cohen, Nashville, Tennessee, USA. 
The achievements thus awarded are of fundamental importance 
for the understanding of how cell growth and survival is driven. 
The general pattern for this process has been known for a 
number of years, but the regulatory mechanisms behind it was 
at the time unknown. Thus the discovery of the first neu- 
rotrophic factor, nerve growth factor (NGF), by Rita Levi- 
Montalcini and of epidermal growth factor (EGF) by Stanley 
Cohen has opened up a completely new and rapidly growing 
field of research of great, basic and clinical, importance and 
interest. As a spin-off effect, we now witness an improved 
understanding of the pathobiology of various diseases, such 
as neurodegenerative diseases, autoimmune diseases, skin 
wounds, and cancers. Today, EGF, an "epitheliotrophin", also 
for skin keratinocytes, is used for in vitro growth of these cells 
under laboratory conditions. This will revolutionize the treat- 
ment in severe burn wounds where the lack of suitable skin 
transplants is critical for the treatment outcome. One cm2 of skin 
from the patient can now, with these new biotechnologies, be 
grown into enough numbers of cutaneous cells to enable the 
coverage of one m2 of injured skin. And this new skin will not 
be rejected, since it originally comes from the patient himself/ 
herself. 
For many years scientists around the world were highly 
fascinated and intrigued by the newly discovered neurons, the- 
ir axons and dendrites, as well as the synaptic contacts they 
established. The neurons were found to be very specialized and 
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differentiated to be able to cope with the various tasks that we 
nowadays understand are based within the nervous system. 
What governs this differentiation process and forms the basis 
for this amazing network of information channels? How can all 
the nerve terminals find their way to the right target cell, and 
how can their synapses be correctly formed and placed? 
The history around the answers to these questions began in 
1947 when a 38-year old Italian developmental biologist, Rita 
Levi-Montalcini, joined Viktor Hamburger at the Washington 
University in St Louis, Missouri, USA. Hamburger, a German 
scientist and one of the embry ologist Hans Spemann' s foremost 
pupils, had come to the US A15 years earlier. The scientific work 
Hamburger had started in his homeland, and continued in the 
USA. He was at the time appreciated as the greatest in the field 
of experimental neuroembryology. 
Rita Levi-Montalcini was not either untouched by the events 
before and during the Second World War. In 1936, she had 
obtained her MD in Turin, and initiated her specialist training in 
neurology and psychiatry, when Benito Mussolini in June 1938 
struck with his racial laws against nonarians. As Italian with a 
Jewish background, Levi-Montalcini very soon found out that 
all possible ways of progress and carrier were closed for her. She 
was not even allowed to borrow books at the university library. 
She accepted an invitation from the Institute of Neurology in 
Brussels, but already after less than two years she had to return 
to Turin to avoid the coming German invasion of B elgium. There 
was at the moment not any safe place for her at all in Europe, and 
the alternative was to leave for the USA. However, Rita Levi- 
Montalcini decided to stay in Turin with her family, and some- 
thing happened, which clearly shows what kind of scientist she 
was. And continued to be! Since she was locked out from the 
university campus, she built her own neuroembryological labo- 
ratory in her bedroom in the apartment she rented in Turin. The 
equipment consisted only of an incubator for cell and tissue 
culture, an ordinary lamp, a stereomicroscope, a microtome to 
cut thin tissue slices with, and a set of instruments she had 
produced herself from sewing needles. Her "bible" at the time 
was Viktor Hamburger's paper, entitled "The effects of wing bud 
extirpation on the development of the central nervous system 
in chick embryos", published in Journal of Experimental Zool- 
ogy 1934; 68:449-494. Ather laboratory, RitaLevi-Montalcini 
was assisted by her previous teacher, the eminent neuroanato- 
mist GiuseppeLevi, also of Jewish origin. It is from his laboratory 
that several of the Italian Nobel Laureates have come: Salvador 
Luria(1969), RenatoDulbecco (1975), and Rita Levi-Montalcini 
(1986). 
Then Turin is attacked, the family escapes to the countryside, 
where Rita Levi-Montalcini tries hard to keep her research 
going. The war is constantly coming closer, Mussolini is 
removed from office, the Nazis are literally flooding Italy, and 
the battue of Jews takes a horrible start. The family of Levi- 
Montalcini took flight to Florence, where they had to live in 
hiding using false identification papers until the end of the war 
inMay!945. 
In 1946, Viktor Hamburger, intrigued by the article by Levi- 
Montalcini and Levi on the role of neuron-target interactions 
during development, published in 1942, invited Levi-Montalcini 
tojoinhiminStLouis.She accepted andby 1947 they had begun 
experiments that resulted in their first joint article, entitled 
"Proliferation, differentiation and degeneration in the spinal 
ganglia of the chick embryo under normal and experimental 
conditions", published in Journal of Experimental Zoology 
1949; 111: 457-502. Hamburger suggests that she shall more 
closely examine some results that one of his previous scholars, 
Elmer Bueker, have got when he transplanted a mouse tumor to 
a chicken embryo. Bueker wanted to observe how a quickly 
growing tissue was furnished with nerve fibers. He received his 
answer, but overlooked certain other, even more astounding 
aspects. RitaLevi-Montalcini did not. Indeed, in collaboration 
with Hamburger, sherepeatedBueker'sexperiments. "Wedid 
not only find that the growth of sensory ganglia from the embryo 
to the tumor (sarcoma 180) increased, but also that the sympa- 
thetic ganglia increased their volume enormously. They became 
5-6 times larger than in the control animals'', RitaLevi-Montalcini 
reported. The neighbouring motor neurons, however, decreased 
their number. How should this be interpreted? "It was an early 
day in the Spring of 1951, as "the stone was rolled away from the 
entrance" and it struck me that the effect of the tumor differed 
from ordinary embryological tissue; the tumor must secrete 
some kind of growth factor of unknown chemical identity." 
When she compared the effects on her experimental animals 
with those found in untreated controls, she found very obvious 
and clear differences. At a time-point, when the outgrowth of 
sympathetic nerve fibers in the control animals not even had 
started, it was at full speed in the abdominal organs of the 
chicken embryos. This evident activity, which was proposed to 
be governed by a diffusible factor derived from the transplanted 
mouse tumor, even went so far that the nerve fibers invaded the 
blood vessels of the embryo. That these phenomena were 
caused by a factor spread via the blood, was decisively proven 
by Rita Levi-Montalcini in anew experiment. She transplanted 
fragments of the mouse tumor outside of the membrane (chorio- 
allantois), which enwraps 4-6 days old chicken embryos. Thus, 
the tumor and the embryo were both supported by the same 
blood supply, but had no direct contact with each other. The 
results of this experiment were identical with the ones received 
when transplanting the tumor tissue directly inside of the 
embryo" To enable the identification of this unknown factor, Rita 
Levi-Montalcini utilized tissue cultures. A scholarship from the 
Rockefeller Foundation gave her the opportunity to realize 
these experiments at the world famous parasitologist Carlos 
Chagas' laboratory at the University in Rio de Janeiro. With two 
mice in her luggage, both with sarcomas transplanted to them, 
RitaLevi-Montalcini came to Rio de Janeiro. The first experi- 
ments failed, but she persistently continued to try to transplant 
tumor tissue to chicken embryos, followed by dissection of 
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small tumor fragment, which she placed in the direct vicinity of 
sensory or sympathetic ganglia in the test tube. "Twenty years 
later I still recall vividly the astonishment I felt when examining 
the results in the microscope", she said in 1975. "I had no camera, 
and did not have time to find one, so, instead, I draw what I saw 
in black ink. Within 12 hours, the nerve fibers had grown radially 
from the sensory and sympathetic ganglia in the close proximity 
to the tumor. It looked like rays from the sun!" Soon this pheno- 
menon became known as the NGF halo. This halo is the most 
sensitive and reliable sign that this growth factor actually is 
present in a certain tissue or body fluid, or not (1). Three months 
after the discovery, Rita Levi-Montalcini returned with her halo 
effect to Hamburger in St Louis, full of enthusiasm and totally 
convinced that the remaining work, to identify and characteri- 
ze the molecule behind this tumor-derived growth factor, only 
should be a matter of a few months' work. The reality turned out 
completely different. It should actually take more than 20 years 
to solve all the chemical issues around this factor, and much of 
this achievement was enabled due to a very skilled biochemist, 
namely Stanley Cohen. Stanley Cohen was at the time specialist 
regarding urea from earthworms. He had actually collected 
several tons (!) of these animals outside of Denver, Colorado. 
Luckily, he right then worked at the Washington University in 
St Louis, heard about the peculiar halo effect, and decided to join 
the research unit of Hamburger and Levi-Montalcini. In an 
extract from the mouse sarcoma, Cohen found the active sub- 
stance within small cytoplasmic particles. In 1954, the growth 
factor was named nerve growth-stimulating factor, later short- 
ened to nerve growth factor, and hence abbreviated as NGF. 
The fraction contained both proteins and nucleic acids. It was 
now up to the scientists to find out in what molecular category 
that NGF was to be found. "If we digest the nucleic acids in the 
active fraction and this leads to the disappearance of the 
growth-promoting effect, we can suspect that NGF is connected 
to the nucleic acids", they said. "However, if the effect still 
remains intact after the removal of the nucleic acids, we instead 
ought to find NGF in the protein pool." Stanley Cohen now 
followed the advice given by the colleague Arthur Kornberg, at 
the Stanford University in San Francisco, Nobel Laureate in 
Physiology or Medicine in 1959 together with Severo Ochoafor 
the discovery of the mechanism behind the biological synthesis 
of RNA and DNA. The piece of advice was that he should use 
snake venom to digest the nucleic acids, since certain snake 
venoms contain a special enzyme, phosphodiesterase, which 
will destroy the nucleic acids. Cohen did exactly this. However, 
now something happened that first was regarded as a complete 
failure, but turned out to be one of the really lucky event. The 
history of science is filled with such coincidences. Rita Levi- 
Montalcini herself said "that it was as to find a hiding place for 
treasures!" One early Spring morning in 1956, when the scien- 
tists as usual inspected the tissue cultures, which had been 
prepared the day before, they found that the snake venom had 
amplified the NGF effect in amost astounding way. The normally 
tender halo of nerve fibers had been transformed into a large halo 
with a tremendously thick fiber growth. This meant that either 
the snake venom had destroyed an inhibitory factor in the tumor 
fraction or actually itself contained NGF. Six hours later they had 
the answer: if they put diluted snake venom alone to the culture 
medium, the effect on the sensory and sympathetic nerve cells 
was the same as if they treated the NGF-containing tumor 
fraction with the snake venom. The snake venom therefore 
contained NGF, in a concentration approximately 1000 times 
higher than in the mouse tumor. Suddenly, Cohen had in his 
hands a source of NGF which allowed full scale biochemical 
characterizations, and soon he found that the snake venom NGF 
is a protein molecule. With this result, Cohen and Levi- 
Montalcini, as well as other research groups in the world, soon 
could characterize the same, or similar, NGF from other tissues 
and body fluids. The big surprise, though, for Cohen and Levi- 
Montalcini was the finding of NGF in the male mouse submax- 
illary glands. The tubular cellsofthese glands produce NGF as 
an oligomeric macromolecule (7S NGF) that is 10 times more 
active, on a molar basis, than the one in snake venom, and 10 
000 times more active than tumor-derived NGF. 
In 1971,20 years after RitaLevi-Montalcini's discovery of the 
nerve growth-stimulating factor, Angeletti and Bradshaw iden- 
tified the amino acid sequence of beta subunit of NGF (beta- 
NGF, also known as 2.5S NGF) purified from mouse submaxillary 
gland. In its active form, NGF is a homodimer, each chain with 
molecular weight of 13 250 D, and containing 118 amino acids, 
connected through three disulphide bridges. Subsequently, in 
1983, Korsching and Thoenen developed a sensitive two-site 
immunoassay, allowing the detection of NGF in target organs. 
With this method it became possible to demonstrate a strong 
correlation between the density of sympathetic innervation and 
target levels of NGF, a finding consistent with the neurotrophic 
theory. Indeed, today the validity of the neurotrophic theory for 
understanding life and death at neuronal level stands as a 
crowning achievement of more than 60 years of pursuit by 
countless investigators. 
THE NEUROTROPHINS AMD THEIR RECEPTORS 
The known members of the NGF gene family, named neuro- 
trophins, includes NGF, neurotrophin 3 (NT-3), NT-4/5, NT-6, 
and brain-derived neurotrophic factor (BDNF). The neurotrophin 
receptors (NTRs) have been named according to the binding 
constant, as low- and high- affinity receptors. The low-affinity 
receptor, p75NGF receptor (p75NGFR, also abbreviated as p75 
LNGFR, or p75NTR) is a member of the tumor necrosis factor 
(TNF) receptor family (2). This receptor binds all known 
neurotrophins with similar affinity. The high-affinity NTRs are 
members of the tyrosine kinase (Trk) receptor family, which 
includes (/) TrkA (gp 140), preferentially binding NGF, (ii) TrkB 
(gp!45),preferentially binding BDNF and NT-4/5, and(m)TrkC 
(gp!45),bindingsolely NT-3 (2-4). The presence of p75NGFR, 
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a coreceptor of Trk, increases the affinity of TrkA for NGF, 
and hence enhances the sensitivity of TrkA-mediated neu- 
ronal response to NGF (4,5). On the other hand, NGF can 
enhance the NGFR expression (6). By targeted mutation of 
p75NGFR in mouse embryonic stem cells, a markedly de- 
creased sensory innervation by calcitonin gene-related pep- 
tide (CGRP) and substance P (SP) immunoreactive nerves 
was found, accompanied by loss of heat sensitivity and by 
development of ulcers in the distal extremities (7). Nonethe- 
less, without p75NGFR, Trk receptors are still capable of 
mediating many important functions (8), while p75NGFR 
may be involved either in independent signaling leading to 
programmed cell death (9) or in NGF-p75-ceramide signaling 
pathway promoting outgrowth of neurons (10). In addition, 
neurotrophic molecules that do not belong to the neurotrophin 
family have also been identified. Examples include glial cell 
line-derived neurotrophic factor (GDNF) (11), ciliary neu- 
rotrophic factor (CNTF) (12), and insulin-like growth factors 
(IGFs), transforming growth factors (TGFs), and fibroblast 
growth factors (FGFs) (13,14). 
THE SKIM 
The skin consists of epidermis, dermis, and hypodermis. The 
epidermis is a continually renewing, stratified squamous epithe- 
lium that keratinizes and gives rise to nails and also piloseba- 
ceous apparatus and sweat glands. The epidermis thickness is 
approximately 0.4 to 1.5 mm, whereas whole thickness of the skin 
is 1.5 to 4 mm. The dermis is composed of densely-packed 
collagen fibers, and fibroblasts dispersed among them, whereas 
the hypodermis is composed of subcutaneous white adipose 
tissue. The skin impedes the penetration of microorganisms, 
absorbs and blocks radiation, and inhibits the loss of water. It 
contains several types of sensory receptors, is involved in 
temperature regulation, and functions in immunologic surveil- 
lance. Each function associates with a specific region of the skin, 
with a specific cell type, and/or with a specific cellular organelle. 
THE NEUROTROPHINS AMD THEIR RECEPTORS IM THE SKIN 
Neurotrophins not only are involved in neuronal differentiation 
and survival, but also exert specific actions on nonneuronal 
tissues, including in the skin. NGF transcripts have been iden- 
tified in normal human keratinocytes in primary and secondary 
cultures, and expression of mRNA
NGF
 was strongly down- 
regulated by corticosteroids (15,16). The keratinocyte-derived 
NGF is secreted in a biologically active form as assessed by 
neurite induction in sensory neurons obtained from chick 
embryo dorsal root ganglia (15). Normal human keratinocytes in 
culture express low- and high-affinity NGFR, and NGF signifi- 
cantly stimulates the proliferation of normal human keratinocytes 
in culture, in a dose-dependent manner (16). Intriguingly, normal 
mouse epidermal keratinocytes in situ are targets for B DNF, NT- 
3, and NT-4, and hence these neurotrophins can also act as 
"epitheliotrophins", controling epidermalhomeostasis(16a). In 
human skin, at light microscopic level, p75NGFR immunoreac- 
tivity has been localized in cutaneous nerves as well as in certain 
basal keratinocytes (17), and in Meissner and Pacinian cor- 
puscles of the human digital skin (18). At ultrastructural level, 
p75NGFR immunoreacti vity has been found in the rat lower lip 
and in primary and permanent canine tooth pulps of the cat 
(19,20). Ourrecentresults have revealed that p75NGFRis main- 
ly associated with both Schwann cell membranes and perineu- 
rium cell membranes in human cutaneous nerve fibers, whereas 
a minute p75NGFR immunoreacti vity wasfoundin axonalmem- 
branes(21). 
As indicated above, neurotrophins and NTRs are crucially 
involved in the normal development of the peripheral nervous 
system (22-24), including cutaneous nerves (25-28). Mice 
overexpressing NGF in the skin have double the normal number 
of cutaneous sensory neurons, have an increased innervation 
of the skin and spinal cord, and are hyperalgesic (25-27), whe- 
reas those overexpressing BDNF showed notable enhancement 
of hair follicle innervation, larger Meissner corpuscle sensory 
endings, and increased number of Merkel cells (28). Using adye- 
labeled plasma extravasation technique in rats, the extent of 
transmedian reinnervation of the skin by C-fibers in the inferior 
alveolar nerve was observed, suggesting that NGF is essential 
for the development of collateral reinnervation from cutaneous 
C-fibers (29). Likewise, mRNA
NGF
 expression in denervated 
adult rat skin can increase 5-10 fold over normal levels in 
innervated skin, evoking an NGF-dependent collateral sprout- 
ing from neighbouring intact sensory axons (30). Altogether, 
these findings strongly suggest a pivotal role played by NGF in 
cutaneous nerve reconstruction. Moreover, NGF can also affect 
nonneuronal cells in the skin. For instance, NGF modulates 
keratinocyte proliferation in murine skin organ cultures of hair 
follicles from telogen skin, but not anagen skin. This is associ- 
ated with a significant mast cell degranulation, indicating hair 
cycle-dependent effects of NGF on keratinocyte proliferation in 
situ, which may require the presence of mast cells (31). The 
expression of NT-3 and its TrkC receptor in the skin of C57/BL6 
mice is strikingly hair cycle-dependent, with maximal transcript 
and protein expression seen during spontaneous hair follicle 
regression (that is, catagen). These findings suggest that the 
hair follicle is both a source of and target for NT-3 and that NT- 
3-TrkC signaling is functionally important in controling hair 
follicle regression (32). Another neurotrophin, NT-4, is required 
for the survival of a receptor subclass of down-hair follicle 
nerves that innervate a subpopulation of hair follicles (33). 
Furthermore, it is believed that the innervation of epidermis, 
upper dermis, and the upper portion of hair follicles is regulated 
by a competitive balance between promoting and suppressing 
effects of various neurotrophins in the mystacial pad of mice 
(34). In the epidermis, other cell types, along with keratinocytes, 
express neurotrophins and NTRs. During fetal development, 
  
18 Johansson and Liang 
Biomed Rev 10, 1999 
  
  
Merkel cells express p75NGFR and descend into the dermis 
to meet the nerve fibers extending from the subcutaneous 
trunk, and branching to form the subepidermal nerve plexus. 
The expression of NGFR on dermal Merkel cells precedes 
their connection with immunoreactive small nerves (35). 
Cultured human epidermal melanocytes also express 
p75NGFR and TrkC receptor, and hence keratinocyte- and/or 
fibroblast-derived NGF and NT-3 may modulate melanocyte 
gene expression (36,37). In addition, exposure to an NGF 
gradient is chemotactic for epidermal melanocytes and en- 
hances their dendricity, suggesting a paracrine role for NGF 
in human epidermis (36). 
THE NEUROTROPHINS AND THEIR RECEPTORS MEDIATE 
IMMUNE FUNCTIONS AND ARE INVOLVED IN NEUROGENIC 
INFLAMMATION________________________ 
Increasing evidence demonstrates that neurotrophins and NTRs 
play an important role in both immune responses and neuro- 
genic inflammation. Forinstance,TrkB and TrkC receptors were 
found in dendritic cells andmacrophages of tonsilar tissue (38), 
TrkA was expressed in intestine epithelial cells (3 8) and human 
lymphocytes (39), and TrkB in thymic macrophages (40). In 
addition, it was found that human T-lymphocytes secrete and 
respond to NGF via TrkA receptor (41). Indeed, NTR expression 
is widespread in the immune system and other nonneuronal 
tissues'in the rat (42). In response to various stimuli, NGF, for 
example, enhances histamine release from and modulate lipid 
mediator formation by Trk-bearing basophils (43,44), and acti- 
vates macrophages (45). Similarly, eosinophils produce and 
respond to NGF and, for instance, NGF induces a selective 
release of proinflammatory mediators, and promotes survival 
and cytotoxicity of human eosinophils (46,47). Further, in NGF 
transgenic mice, an increased number in sympathetic nerves in 
lymph nodes is found (48), while in inflamed tissues, NGF 
contributes to the progressive tactile hyperalgesia elicited by 
repeated touch stimulation (49). In rat experiments, NGF can 
restore neurogenic microvascular responses towards normal 
(50). Local injection of NGF can induce thermal hyperalgesia, 
mediated by the induction of a myeloperoxidase-leucotactic 
action, followed by a series of events resulting in the hyperal- 
gesia (51). In rats, experimentally-induced sciatic nerve injury 
leads to an enhanced NGF-mediated hyperalgesia that is re- 
duced by NGF antiserum (52). GDNF and NT-3 can activate the 
immune system in allogenic graft combinations (53). By 
intracerebro ventricular or intravenous injection of high amounts 
of NGF in the rat, phytohaemagglotinin-induced splenocyte 
proliferation was significantly enhanced, while it was com- 
pletely prevented by intracerebro ventricular pretreatment with 
anti-NGF antibodies (54). Inversely, NGF has been shown to 
inhibit certain immune responses, for instance, BL-4-induced IgE 
production. This inhibition was not mediated through blocking 
of CD23 induction nor through IL-4 receptor expression 
inhibition (55). By NGF administered invivo, a significant dose- 
dependent suppression of lymphocyte proliferation was also 
observed (56). Since certain neuropeptides are implicated in 
cutaneous neurogenic inflammation, mostprobably, NGFcould 
mediate these effects, at least in part, through stimulation of 
local neuropeptide synthesis and/or release (cf. Ref. 57). 
Experimental inflammation, produced by Freund's complete 
adjuvant, results in a local sensory hypersensitivity, an up- 
regulation of the SP and CGRP synthesis in the inflamed tissue, 
and an elevation of NGF levels in the skin. Prior systemic 
administration of anti-NGF antibodies prevents the behavioral 
sensitivity, the upregulation of neuropeptide production, and 
the inflammation-induced expression of immediate early c-fos 
gene in dorsal horn neurons, without modifying swelling and 
erythema (5 8; also see 59). NGF also stimulates CGRP synthesis 
in primary afferent neurons without causing long-lasting changes 
in thermal nociceptive thresholds (60), whereas locally admin- 
istered NGF increases CGRP expression in dorsal root ganglion 
neurons (61). Likewise, NGF can completely recover both CGRP 
and SP content, and still function in capsaicin-impaired sensory 
neurons (62). Evidence is also reported that NGF regulates 
cutaneous C-fiber heat nociceptors in the developing rat (63) 
and that BDNF regulates somatostatin and neuropeptide ty- 
rosine (NPY) expression (64). However, in injured rat lumbar 
dorsal root ganglion neurons, NGF downregulates both CGRP 
and SP but not somatostatin expression (65). Finally, NGF has 
also been demonstrated to stimulate NPY production in human 
lymphocytes (66). 
THE NEUROTROPHINS AND THEIR RECEPTORS IN SKIN 
DISEASES___________________________ 
Rapidly accumulating evidence implicates neurotrophins and 
NTRs, through their effects on multiple immune functions and 
on neurogenic inflammation, in thepathogenesis of numerous 
diseases affecting the skin. In psoriatic skin, for example, an 
increased NGF expression has been observed, and an increased 
number in nerve terminals was associated with increased SP and 
CGRP levels, suggesting that NGF may directly, or through 
neuropeptide release, be involved in the development of pso- 
riasis (67). Furthermore, NGF may increase the mitogenic 
potetial of IGF-1, IGF-2, TGF-p\ and basic FGF in human 
keratinocyte cultures (68). In prurigo nodularis skin, an in- 
creased p75NGFR expression in dermal nerves has been docu- 
mented (69). Overexpression of p75NGFR was mainly found in 
Schwann cell membranes and perineurium cell membranes, 
accompanied by an increased CGRP expression (70) and by 
p75NGFR immunoreactive nerve association with mast cells 
(71). It is note worthy that mast cells are source of and target for 
NGF, and, accordingly, an interactive involvement of NGF and 
mast cells in the pathogenesis of various diseases is increas- 
ingly recognized (reviewed in 72,73). Likewise, NGF is reported 
to induce inhibition of TNF-oc production, implying an antiin- 
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flammatory role of NGF, through effects on mast cells (74). 
Furthermore, NT-3 is shown to be increased in the skin of human 
diabetic neuropathy (75), whereas TrkA and TrkC expression 
increased in human diabetic skin (76). Moreover, NGF, by 
upregulating bcl-2 expression, rescues melanocytes from ul- 
traviolet-induced apoptosis, suggesting that keratinocyte-de- 
rived NGF may be protective to melanocytes (77). Likewise, 
experimental skin wound is accompanied by an increased 
expression of NGF (78,79), whereas topically applied NGF 
accelerates the healing rate in normal and healing-impaired 
diabetic mice (78). These findings suggest that the endogenous 
NGF secretion is insufficient for complete restoration of skin 
integrity in wound healing, and hence exogenous administra- 
tion of NGF is required to benefit the healing process. Impor- 
tantly, this is also thecase with human ulcers: topical treatment 
with NGF promotes the healing of corneal (80) and skin (81) 
ulcers. 
CONCLUSION AMD PERSPECTIVES 
Evidence presented here shows that neurotrophins and their 
receptors play an important role in the skin development and 
function as well as in the pathogenesis of certain skin diseases. 
Also, neurotrophins, in particular NGF, have no longerpredomi- 
nantly been considered under the aspect of their function in 
regulating neuronal differentiation and survival. Instead, these 
molecules are well recognized to have a number of potent effects 
on various nonneuronal cells, including immune cells. The 
development of NGFR and Trk receptor agonists and antago- 
nists, as well as enhancers and inhibitors of neurotrophin 
synthesis (82, this volume of Biomedical Reviews), will likely 
lead to a breakthrough in the treatment of certain skin diseases. 
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